DEXCOM INC — Director's Dealing 2021

Mar 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-03-08

Reporting Person: Regan Barry J. (EVP Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-08	Common Stock	A	5301	$0.001	Acquired	13508	Direct

Footnotes

F1: Represents a grant of restricted stock units that are exempt from Section 16 b-3 and are subject to vesting in three equal annual installments from the date of grant. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.

F2: Included in this number are 13,508 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, and 8,207 of which were granted on November 19, 2020 and shall vest through November 19 2024.